Featured News
Press Release
Alzheimer’s Association Welcomes Continued Progress in Alzheimer’s Treatment with FDA Approval of Leqembi Subcutaneous Starter Dose
Chicago, July 13, 2026 — The Alzheimer’s Association welcomes today’s U.S. Food and Drug Administration (FDA) action to approve a subcutaneous starter dose of Leqembi® (lecane...
All News
AIM Blog
Help AIM Grow One Member at a Time
Over the last few years the Alzheimer's Impact Movement (AIM) has begun to drive substantial changes in the way Washington...
Press Release
AIM Honors Rep. Tom Cole (R-OK) and Nita Lowey (D-NY) With 2017 Humanitarian Award
WASHINGTON, D.C., March 28, 2017 - During the Alzheimer's Association National Alzheimer's Dinner, Congressman Tom Cole (R-OK) and Congresswoman Nita...
Press Release
Palliative Care and Hospice Education and Training Act (PCHETA) Introduced in Congress
WASHINGTON, D.C., March 22, 2017 - The Alzheimer's Association and the Alzheimer's Impact Movement (AIM) supports the Palliative Care and...
Press Release
Alzheimer's Association and Alzheimer's Impact Movement Statement on Medicaid Reform Proposals
WASHINGTON, D.C., March 22, 2017 - The Alzheimer's Association and the Alzheimer's Impact Movement are concerned about recent proposals to...
AIM Blog
Amplify Your Advocacy Reach with New Social Media Tools
These days nearly every member of Congress is using Twitter, Facebook or Instagram on a regular basis. The era of...
AIM Blog
Continuing to Drive the Pace of Alzheimer's Research
Last week I testified before the House Labor, Health and Human Services (Labor-HHS) Appropriations Subcommittee about Alzheimer's research funding. I...